Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)

Pharmaceutical Preparations

http://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

222 BERKELEY STREET, 12TH FLOOR
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/05/2017

Market Cap

2,828,049,588

Shares Outstanding

59,100,000

Weighted SO

59,096,454

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

RVMD --.--%

AKRO --.--%

RNA --.--%

PTGX --.--%

STOK --.--%

QURE --.--%

RCKT --.--%

SLDB --.--%

MGTX --.--%

Beta

2.0430

Last Div

0.0000

Range

20.97-53.92

Chg

-0.4400

Avg Vol

507737

Mkt Cap

2828049588

Exch

NASDAQ

Country

US

Phone

857 264 4280

DCF Diff

72.6878

DCF

-25.9878

Div Yield

0.0000

P/S

27.7851

EV Multiple

-11.3720

P/FV

71.7385

Div Yield %

0.0000

P/E

-10.8793

PEG

-1.2318

Payout

0.0000

Current Ratio

6.5306

Quick Ratio

6.3114

Cash Ratio

2.9544

DSO

63.1075

DIO

372.0413

Op Cycle

435.1488

DPO

140.9191

CCC

294.2297

Gross Margin

0.8844

Op Margin

-2.6093

Pretax Margin

-2.5356

Net Margin

-2.5488

Eff Tax Rate

-0.0052

ROA

-0.6794

ROE

-2.2166

ROCE

-0.8119

NI/EBT

1.0052

EBT/EBIT

0.9718

EBIT/Rev

-2.6093

Debt Ratio

0.6530

D/E

6.3376

LT Debt/Cap

0.8633

Total Debt/Cap

0.8637

Int Coverage

-33.8279

CF/Debt

-0.5152

Equity Multi

9.7056

Rec Turnover

5.7838

Pay Turnover

2.5901

Inv Turnover

0.9811

FA Turnover

21.7997

Asset Turnover

0.2666

OCF/Share

-2.1054

FCF/Share

-2.7610

Cash/Share

5.2306

OCF/Sales

-1.2620

FCF/OCF

1.3114

CF Coverage

-0.5152

ST Coverage

-157.4179

CapEx Coverage

-3.2113

Div&CapEx Cov

-3.2113

P/BV

71.7385

P/B

71.7385

P/S

27.7851

P/E

-10.8793

P/FCF

-16.7884

P/OCF

-21.9723

P/CF

-21.9723

PEG

-1.2318

P/S

27.7851

EV Multiple

-11.3720

P/FV

71.7385

DPS

0.0000

Latest Headlines (EST)

Benzinga Jan 04, 11:00 The Analyst Verdict: Rhythm Pharmaceuticals In The Eyes Of 7 Experts

Revenue Product Segmentation